Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board shared a post on LinkedIn:
”Iron deficiency can hide beta-thalassaemia trait.
This creates a real problem in antenatal screening.
Here’s why: Low iron falsely lowers HbA₂ levels. The result? A pregnant woman with beta-thalassaemia trait can get a false-negative result. And that means missed genetic counselling.
The solution is simple. Don’t wait.
Here’s what every obstetric team needs to know:
Screen at booking, even if iron deficiency is suspected. Don’t delay haemoglobin variant analysis.
Borderline HbA₂ (3.0-3.4%) with low ferritin (<30 µg/L)? Start iron therapy and retest after 8-12 weeks.
Test the partner in parallel if the maternal result is positive or borderline. Time matters.
When results remain unclear, escalate to DNA testing. Don’t guess.
The UK NHS Sickle Cell and Thalassaemia Screening Programme is clear on this: Timing keeps options open for couples who may be at risk of having a child with thalassaemia major.
Are you seeing borderline HbA₂ results in your antenatal patients? How do you handle them?”

More posts from Dr Abdul Mannan on Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke